⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DBVT News
DBV Technologies S.A.
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
globenewswire.com
DBVT
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
globenewswire.com
AMGN
AZN
DBVT
GSK
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
globenewswire.com
DBVT
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
globenewswire.com
DBVT
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
globenewswire.com
DBVT
DBV Technologies to Participate in Upcoming March Investor Conferences
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
globenewswire.com
DBVT